NSE · FDC.NS
FDC Limited
₹378.90+₹1.75 (+0.46%)
FDC Limited’s quoted price sits in the lower half of its reported 52-week range, 20.0% below the high.
Loading market information…
BSE · ZENOTECH.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 05:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Zenotech Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 28.89% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zenotech Laboratories Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zenotech Laboratories Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of various medical products. Notably, its production activities include granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GMCSF). The company's range of injectable offerings is strategically targeted at niche therapeutic areas such as oncology (cancer treatment) and anesthesiology. Founded on June 15, 1989, Zenotech Laboratories Ltd. maintains its headquarters in Hyderabad, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:30 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹378.90+₹1.75 (+0.46%)
FDC Limited’s quoted price sits in the lower half of its reported 52-week range, 20.0% below the high.
₹414.95-₹3.85 (-0.92%)
Gufic Biosciences Limited’s quoted price sits in the upper half of its reported 52-week range, 11.3% below the high.
₹1,391.00-₹59.60 (-4.11%)
Fredun Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 16.52% below the high.
₹422.60-₹8.05 (-1.87%)
Trident Lifeline Limited’s quoted price sits in the upper half of its reported 52-week range, 3.49% below the high.
₹77.70+₹1.45 (+1.9%)
Lyka Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 20.92% below the high.
₹414.45+₹14.15 (+3.53%)
BDH Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 32.06% below the high.
₹173.50+₹5.10 (+3.03%)
Sanjivani Paranteral Limited.’s quoted price sits in the lower half of its reported 52-week range, 28.89% below the high.
₹102.95+₹1.80 (+1.78%)
Panchsheel Organics Limited’s quoted price sits in the lower half of its reported 52-week range, 33.32% below the high.
